• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于肾皮质超声容积测量法的肾功能回归方程。

Regression equation for kidney function based on the ultrasonographic volumetry of the renal cortex.

作者信息

Hoi Shotaro, Takata Tomoaki, Fujino Yudai, Kageyama Kana, Taniguchi Sosuke, Yoshida Yukina, Mae Yukari, Iyama Takuji, Sugihara Takaaki, Isomoto Hajime

机构信息

Division of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Nishi-cho 36-1, Yonago, Tottori, 683-8504, Japan.

School of Health Science, Major in Clinical Laboratory Science, Faculty of Medicine, Tottori University, Nishi-cho 36-1, Yonago, Tottori, 683-8504, Japan.

出版信息

J Nephrol. 2025 Sep 8. doi: 10.1007/s40620-025-02417-z.

DOI:10.1007/s40620-025-02417-z
PMID:40920286
Abstract

BACKGROUND

Chronic kidney disease (CKD) is a public health concern; kidney size correlates with kidney function, except in diabetic kidney disease (DKD), where the kidney enlarges, limiting morphological measurement applications in CKD management. However, cortical size changes in DKD along with CKD progression remain understudied. We investigated kidney morphology alterations in patients with and without diabetes and established a regression equation for kidney function incorporating morphological alterations.

METHODS

We included 312 patients who underwent kidney morphological measurements at Tottori University Hospital between 2018 and 2024. After excluding 34 subjects, 278 patients were divided into derivation and validation groups. Ultrasonography was used to assess kidney morphology including parenchymal, cortical, and medullary thicknesses, length, and kidney and cortical volumes. The non-diabetic and diabetic groups were compared at each CKD stage. Multivariate linear regression generated renal function equations.

RESULTS

In the derivation group (247 patients), height-adjusted cortical volume was strongly associated with kidney function in patients without diabetes (r = 0.513, p < 0.001) and with diabetes (r = 0.701, p < 0.001). Cortical volume was significantly larger in patients with than in those without diabetes at each CKD stage, except stages 4 and 5. In the validation group (31 patients), the predicted estimated glomerular filtration rate (eGFR) strongly correlated with the actual eGFR (r = 0.803, p < 0.001).

CONCLUSIONS

A strong correlation between cortical size and kidney function was observed. Cortical size alterations depended on the cause of CKD. A regression equation incorporating kidney size can help assess the eGFR. These findings could help formulate strategies for improving CKD management.

摘要

背景

慢性肾脏病(CKD)是一个公共卫生问题;肾脏大小与肾功能相关,但糖尿病肾病(DKD)除外,在DKD中肾脏会增大,这限制了形态学测量在CKD管理中的应用。然而,DKD中皮质大小随CKD进展的变化仍未得到充分研究。我们调查了糖尿病患者和非糖尿病患者的肾脏形态改变,并建立了一个纳入形态学改变的肾功能回归方程。

方法

我们纳入了2018年至2024年在鸟取大学医院接受肾脏形态测量的312例患者。排除34例受试者后,将278例患者分为推导组和验证组。采用超声检查评估肾脏形态,包括实质、皮质和髓质厚度、长度以及肾脏和皮质体积。在每个CKD阶段对非糖尿病组和糖尿病组进行比较。多变量线性回归生成肾功能方程。

结果

在推导组(247例患者)中,身高校正后的皮质体积与非糖尿病患者(r = 0.513,p < 0.001)和糖尿病患者(r = 0.701,p < 0.001)的肾功能密切相关。在每个CKD阶段,除4期和5期外,糖尿病患者的皮质体积显著大于非糖尿病患者。在验证组(31例患者)中,预测的估计肾小球滤过率(eGFR)与实际eGFR密切相关(r = 0.803,p < 0.001)。

结论

观察到皮质大小与肾功能之间存在密切相关性。皮质大小改变取决于CKD的病因。纳入肾脏大小的回归方程有助于评估eGFR。这些发现有助于制定改善CKD管理的策略。

相似文献

1
Regression equation for kidney function based on the ultrasonographic volumetry of the renal cortex.基于肾皮质超声容积测量法的肾功能回归方程。
J Nephrol. 2025 Sep 8. doi: 10.1007/s40620-025-02417-z.
2
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
3
Assessing Renal Function in Chronic Kidney Disease: A Comparative Evaluation of Glomerular Filtration Rate Prediction Equations in the North-Central Region of Nigeria.评估慢性肾脏病患者的肾功能:尼日利亚中北部地区肾小球滤过率预测方程的比较评价
Cureus. 2025 May 21;17(5):e84577. doi: 10.7759/cureus.84577. eCollection 2025 May.
4
Association of Kidney Cysts With Progressive CKD After Radical Nephrectomy.肾囊肿与根治性肾切除术后进行性 CKD 的关系。
Am J Kidney Dis. 2024 Jul;84(1):62-72.e1. doi: 10.1053/j.ajkd.2023.11.016. Epub 2024 Jan 26.
5
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂用于患有早期(1至3期)非糖尿病慢性肾病的成人。
Cochrane Database Syst Rev. 2011 Oct 5(10):CD007751. doi: 10.1002/14651858.CD007751.pub2.
6
Impact of the 2021 Chronic Kidney Disease Epidemiology Collaboration glomerular filtration rate estimating equation on risk of healthcare utilization for hospitalizations for cardiovascular and kidney disease.2021年慢性肾脏病流行病学协作组肾小球滤过率估算方程对心血管疾病和肾脏疾病住院医疗利用风险的影响
Nephron. 2025 Aug 4:1-20. doi: 10.1159/000547627.
7
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在患有早期(1 至 3 期)非糖尿病慢性肾脏病的成人中的应用。
Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD007751. doi: 10.1002/14651858.CD007751.pub3.
8
Cardiovascular Disease Risk Estimates in the US CKD Population Using the PREVENT Equation.使用PREVENT方程对美国慢性肾脏病患者群体进行心血管疾病风险评估。
Am J Kidney Dis. 2025 Mar 5. doi: 10.1053/j.ajkd.2025.01.012.
9
Evaluation of race-free eGFR equations in individuals of different ethnicity.不同种族个体中无种族因素的估算肾小球滤过率(eGFR)方程的评估。
Blood Press. 2025 Dec;34(1):2533456. doi: 10.1080/08037051.2025.2533456. Epub 2025 Jul 22.
10
Kidney Outcomes in Patients With Advanced Heart Failure Treated With Ventricular Assist Devices.接受心室辅助装置治疗的晚期心力衰竭患者的肾脏结局
Kidney Med. 2025 May 16;7(7):101027. doi: 10.1016/j.xkme.2025.101027. eCollection 2025 Jul.

本文引用的文献

1
Beyond creatinine: New methods to measure renal function?超越肌酐:测量肾功能的新方法?
Eur J Intern Med. 2025 Apr;134:17-24. doi: 10.1016/j.ejim.2025.01.015. Epub 2025 Jan 31.
2
Managing Dosage Adjustments in Pseudo-Hypocreatinemia: Insights from Vancomycin-Induced Nephrotoxicity in a Sarcopenic Patient.假性低促胰液素血症的剂量调整管理:来自一名肌肉减少症患者万古霉素诱导的肾毒性的见解
Yonago Acta Med. 2024 Oct 23;67(4):358-362. doi: 10.33160/yam.2024.11.005. eCollection 2024 Nov.
3
Transition from acute kidney injury to chronic kidney disease: mechanisms, models, and biomarkers.
从急性肾损伤到慢性肾脏病的转变:机制、模型和生物标志物。
Am J Physiol Renal Physiol. 2024 Nov 1;327(5):F788-F805. doi: 10.1152/ajprenal.00184.2024. Epub 2024 Sep 19.
4
Zinc deficiency induces hypertension by paradoxically amplifying salt sensitivity under high salt intake in mice.缺锌通过在高盐摄入下反常地放大盐敏感性而导致高血压。
Clin Exp Nephrol. 2024 Aug;28(8):728-739. doi: 10.1007/s10157-024-02478-7. Epub 2024 Apr 6.
5
The Versatile Role of Uromodulin in Renal Homeostasis and Its Relevance in Chronic Kidney Disease.尿调素在肾脏稳态中的多功能作用及其在慢性肾脏病中的相关性。
Intern Med. 2024 Jan 1;63(1):17-23. doi: 10.2169/internalmedicine.1342-22. Epub 2023 Jan 15.
6
Targeting a Silent Disease: Vascular Calcification in Chronic Kidney Disease.靶向沉默之疾:慢性肾脏病中的血管钙化。
Int J Mol Sci. 2022 Dec 17;23(24):16114. doi: 10.3390/ijms232416114.
7
Steatosis is involved in the progression of kidney disease in a high-fat-diet-induced non-alcoholic steatohepatitis mouse model.脂肪变性参与高脂肪饮食诱导的非酒精性脂肪性肝炎小鼠模型中肾脏疾病的进展。
PLoS One. 2022 Mar 16;17(3):e0265461. doi: 10.1371/journal.pone.0265461. eCollection 2022.
8
Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors: Renoprotective Mechanisms beyond Glycemic Control.钠-葡萄糖共转运蛋白 2 抑制剂的多效作用:血糖控制以外的肾保护机制。
Int J Mol Sci. 2021 Apr 22;22(9):4374. doi: 10.3390/ijms22094374.
9
Estimating the prevalence of definitive chronic kidney disease in the Japanese general population.估算日本普通人群中明确的慢性肾脏病的患病率。
Clin Exp Nephrol. 2021 Aug;25(8):885-892. doi: 10.1007/s10157-021-02049-0. Epub 2021 Apr 10.
10
Contribution of Predictive and Prognostic Biomarkers to Clinical Research on Chronic Kidney Disease.预测和预后生物标志物对慢性肾脏病临床研究的贡献。
Int J Mol Sci. 2020 Aug 14;21(16):5846. doi: 10.3390/ijms21165846.